Browsing by Author "Shaw, Alice Tsang"
Now showing items 1-4 of 4
-
Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer
Shaw, Alice Tsang; Johnson, Melissa L.; Navarro Mendivil, Alejandro; Gainor, Justin F.; Thurm, Holger; Felip Font, Enriqueta; Bauer, Todd (Springer, 2020-02) -
Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study
Felip Font, Enriqueta; de Braud, Filippo G.; Maur, Michela; Loong, Herbert H.; Shaw, Alice Tsang; Vansteenkiste, Johan F. (Elsevier, 2020-03) -
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs
Felip Font, Enriqueta; Shaw, Alice Tsang; Bearz, A.; Camidge, D. R.; Bauman, J. R.; Solomon, Benjamin (Elsevier, 2021-05) -
Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer
Iadeluca, Laura; Shaw, Alice Tsang; de Marinis, Filippo; Felip Font, Enriqueta; Solomon, Benjamin; Bauer, Todd; Mazieres, Julien (Elsevier, 2022-12)